NCT07053176View on ClinicalTrials.gov

Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
Cervicogenic Dizziness
Interventions
DRUG

0.5% Lidocaine

0.5% lidocaine injection will be administered in the paravertebral intramuscular region with 12 mm, 30 G needle from C2 to C7 bilaterally

DRUG

Saline Solution (NaCl 0,9%)

saline solution will be administered bilaterally in the paravertebral intamuscular region from C2 to C7 with 12 mm 30 G needle

Trial Locations (1)

02032

Uniter Onlus, Fara in Sabina

All Listed Sponsors
lead

Uniter Onlus

OTHER